导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.76% | 47/197 |
| 近一周 | -1.32% | 17/203 |
| 近一月 | -2.75% | 75/203 |
| 近一季 | -0.22% | 48/203 |
| 近半年 | 12.37% | 46/199 |
| 近一年 | 9.28% | 47/194 |
| 近两年 | 28.74% | 93/168 |
| 近三年 | 61.25% | 35/133 |
| 成立以来 | 334.62% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.18% 181/360 |
13.21% 110/366 |
- - |
- - |
| 2025 | 13.89% 247/358 |
-4.76% 226/340 |
10.35% 128/348 |
7.00% 245/354 |
1.28% 90/358 |
| 2024 | 25.30% 43/329 |
10.42% 34/280 |
4.42% 113/310 |
3.72% 184/318 |
4.78% 76/329 |
| 2023 | 26.09% 51/275 |
5.19% 72/205 |
13.90% 51/230 |
-3.90% 112/262 |
9.52% 95/276 |
| 2022 | -11.94% 54/201 |
-5.34% 39/153 |
-11.62% 101/164 |
-0.03% 38/189 |
5.30% 129/202 |
| 2021 | 24.32% 27/150 |
6.64% 48/312 |
6.41% 115/328 |
0.65% 69/358 |
8.84% 39/151 |
| 2020 | 9.53% 43/103 |
-18.53% 212/280 |
20.07% 98/295 |
4.38% 103/299 |
7.27% 167/305 |
| 2019 | 31.64% 17/88 |
11.25% 101/258 |
6.06% 18/268 |
4.11% 37/253 |
7.17% 112/266 |
| 2018 | -1.18% 17/79 |
- - |
- - |
- - |
-13.94% 160/241 |
| 2017 | 13.02% 41/69 |
- - |
- - |
- - |
- - |
| 2016 | 17.58% 6/59 |
- - |
- - |
- - |
- - |
| 2015 | 6.95% 7/49 |
- - |
- - |
- - |
- - |
| 2014 | 13.38% 17/99 |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 博时标普500ETF VS. 建信富时100指数(QDII)人民币A(539003) |